Proteomic Analysis of Low-Grade Serous Ovarian Cancer and Comparing It with Non-cancerous Ovarian

被引:1
|
作者
Bashizadeh Fakhar H. [1 ]
Rezaie-Tavirani M. [1 ]
Zali H. [2 ]
Darkhaneh R.F. [3 ]
Nejad E.K. [4 ]
Aghazadeh M.H. [5 ]
机构
[1] Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran
[2] Proteomics Research Center, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran
[3] Department of Obstetrics and Gynecology, Reproductive Health Research Center, Guilan University of Medical Sciences, Rasht, Guilan
[4] Department of Biostatistics, Guilan Road Truma Research Center, Guilan University of Medical Sciences, Rasht
[5] Azad Medical University, Tehran
关键词
Comparison; Low-grade serous ovarian cancer; Non-cancerous ovarian; Proteomics;
D O I
10.1007/s40944-018-0187-8
中图分类号
学科分类号
摘要
Background: In Iran, ovarian cancer is the eighth most common cancer. Serous is considered as the most common of all ovarian cancers. It is usually deadly due to late diagnosis. Moreover, as all studies so far have considered metastatic or high-stage ovarian cancer, this study sought low-grade ovarian serous in human, which is of high importance and aimed at obtaining protein biomarkers that may be useful in diagnosis and treatment of ovarian serous cancer. Materials and Methods: In this experimental study, ten patients with proved low-grade serous ovarian cancer and ten women without ovarian cancer, healthy, and cancerous tissue samples were obtained to perform proteomics. All tissue proteins were purified using standard separation methods, and proteins were separated using two-dimensional electrophoresis. Healthy and tumorous tissue proteomes were compared, and the extent of protein expression was analyzed. Results: This study identified 212 proteins, 41 of which had changes in protein expression in cancer state. The expression of eight proteins was suppressed, and five proteins were expressed in cancerous group. Thirteen proteins in cancer sample showed increase in expression and 15 proteins reduced expression in cancerous tissue. Conclusion: It seems that in this disease, the expression of a large number of proteins in cancerous tissues changed, most of them decreased or not expressed at all. These changed proteins can be effective as biomarker in diagnosis and treatment of this disease. © 2018, Association of Gynecologic Oncologists of India.
引用
下载
收藏
相关论文
共 50 条
  • [31] Low-Grade Serous Ovarian Carcinoma: Challenges and Solutions
    Patni, Ranu
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 20 (04)
  • [32] Ovarian low-grade serous carcinoma: A comprehensive update
    Diaz-Padilla, Ivan
    Malpica, Anais L.
    Minig, Lucas
    Chiva, Luis M.
    Gershenson, David M.
    Gonzalez-Martin, Antonio
    GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 279 - 285
  • [33] Immunosuppressive microenvironment in low-grade serous ovarian carcinoma
    Wong, Kwong-Kwok
    Gershenson, David M.
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Estrogen signaling in low-grade serous ovarian carcinoma
    Tsang, Yvonne T. M.
    Ng, Chun Wai Oscar
    Gershenson, David
    Wong, K-Kwok
    CANCER RESEARCH, 2023, 84 (06)
  • [35] Current concept of low-grade serous ovarian carcinoma
    Nakayama, Kentaro
    Razia, Sultana
    Ishibashi, Tomoka
    Kyo, Satoru
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (01) : 6 - 10
  • [36] The role of smoking in low-grade serous ovarian carcinoma
    Schlumbrecht, M.
    Sun, C.
    Wong, K.
    Broaddus, R.
    Gershenson, D.
    Bodurka, D.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S123 - S124
  • [37] Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
    Dey, Puja
    Nakayama, Kentaro
    Razia, Sultana
    Ishikawa, Masako
    Ishibashi, Tomoka
    Yamashita, Hitomi
    Kanno, Kosuke
    Sato, Seiya
    Kiyono, Tohru
    Kyo, Satoru
    CANCERS, 2022, 14 (06)
  • [38] Tubal origin of 'ovarian' low-grade serous carcinoma
    Li, Jie
    Abushahin, Nisreen
    Pang, Shujie
    Xiang, Li
    Chambers, Setsuko K.
    Fadare, Oluwole
    Kong, Beihua
    Zheng, Wenxin
    MODERN PATHOLOGY, 2011, 24 (11) : 1488 - 1499
  • [39] Low-Grade Serous Ovarian Carcinoma: Challenges and Solutions
    Ranu Patni
    Indian Journal of Gynecologic Oncology, 2022, 20
  • [40] Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum
    Hinson, Stacy A.
    Silva, Elvio G.
    Pinto, K.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2013, 17 (03) : 302 - 304